|
1
|
Zhang F, Yang Z, Cao M, et al: MiR-203
suppresses tumor growth and invasion and down-regulates MiR-21
expression through repressing Ran in esophageal cancer. Cancer
Lett. 342:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang F, Li X, Xie X, Zhao L and Chen W:
UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma
and embryo, influencing cell growth and promoting invasion. FEBS
Lett. 582:1919–1927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu ZH, Wang XL, Tang HM, et al: Long
non-coding RNA HOTAIR is a powerful predictor of metastasis and
poor prognosis and is associated with epithelial-mesenchymal
transition in colon cancer. Oncol Rep. 32:395–402. 2014.PubMed/NCBI
|
|
4
|
Li H, Yu B, Li J, et al: Overexpression of
lncRNA H19 enhances carcinogenesis and metastasis of gastric
cancer. Oncotarget. 5:2318–2329. 2014.PubMed/NCBI
|
|
5
|
Gutschner T, Hämmerle M, Eissmann M, et
al: The noncoding RNA MALAT1 is a critical regulator of the
metastasis phenotype of lung cancer cells. Cancer Res.
73:1180–1189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Wen M, Kwon Y, et al: CUL4A
induces epithelial-mesenchymal transition and promotes cancer
metastasis by regulating ZEB1 expression. Cancer Res. 74:520–531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu J, Ruan B, You N, et al:
Downregulation of miR-200a induces EMT phenotypes and CSC-like
signatures through targeting the β-catenin pathway in hepatic oval
cells. PLoS One. 8:e794092013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong H, Xie L, Tang C, et al: Snail1
correlates with patient outcomes in E-cadherin-preserved
gastroesophageal junction adenocarcinoma. Clin Transl Oncol.
16:783–791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Li H, Feng J, et al: Lin28 induces
epithelial-to-mesenchymal transition and stemness via
downregulation of let-7a in breast cancer cells. PLoS One.
8:e830832013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bao YX, Cao Q, Yang Y, et al: Expression
and prognostic significance of golgiglycoprotein73 (GP73) with
epithelial-mesenchymal transition (EMT) related molecules in
Hepatocellular Carcinoma (HCC). Diagn Pathol. 8:1972013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Jiang G, Zhou J, et al:
Down-regulation of miR-140 induces EMT and promotes invasion by
targeting Slug in esophageal cancer. Cell Physiol Biochem.
34:1466–1476. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hibi K, Nakamura H, Hirai A, et al: Loss
of H19 imprinting in esophageal cancer. Cancer Res. 56:480–482.
1996.PubMed/NCBI
|
|
13
|
Shigaki H, Baba Y, Watanabe M, Murata A,
Ishimoto T, Iwatsuki M, Iwagami S, Nosho K and Baba H: PIK3CA
mutation is associated with a favorable prognosis among patients
with curatively resected esophageal squamous cell carcinoma. Clin
Cancer Res. 19:2451–2459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koshy M, Esiashvilli N, Landry JC, Thomas
CR Jr and Matthews RH: Multiple management modalities in esophageal
cancer: combined modality management approaches. Oncologist.
9:147–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang X, Song JH, Cheng Y, et al: Long
non-coding RNA HNF1A-AS1 regulates proliferation and migration in
oesophageal adenocarcinoma cells. Gut. 63:881–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ge XS, Ma HJ, Zheng XH, et al: HOTAIR, a
prognostic factor in esophageal squamous cell carcinoma, inhibits
WIF-1 expression and activates Wnt pathway. Cancer Sci.
104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kitamura K, Seike M, Okano T, et al:
MiR-134/487b/655 cluster regulates TGF-β-induced
epithelial-mesenchymal transition and drug resistance to gefitinib
by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther.
13:444–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo S, Xu X, Tang Y, et al: miR-15a
inhibits cell proliferation and epithelial to mesenchymal
transition in pancreatic ductal adenocarcinoma by down-regulating
Bmi-1 expression. Cancer Lett. 344:40–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamada S, Fuchs BC, Fujii T, et al:
Epithelial-to-mesenchymal transition predicts prognosis of
pancreatic cancer. Surgery. 154:946–954. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou P, Zhao Y, Li Z, et al: LincRNA-ROR
induces epithelial-to-mesenchymal transition and contributes to
breast cancer tumorigenesis and metastasis. Cell Death Dis.
5:e12872014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun M, Liu XH, Wang KM, et al:
Downregulation of BRAF activated non-coding RNA is associated with
poor prognosis for non-small cell lung cancer and promotes
metastasis by affecting epithelial-mesenchymal transition. Mol
Cancer. 13:682014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vitalone MJ, Naesens M, Sigdel T, Li L,
Hseih S and Sarwal MM: The dual role of epithelial-to-mesenchymal
transition in chronic allograft injury in pediatric renal
transplantation. Transplantation. 92:787–795. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
López-Novoa JM and Nieto MA: Inflammation
and EMT: An alliance towards organ fibrosis and cancer progression.
EMBO Mol Med. 1:303–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mucsi I and Rosivall L:
Epithelial-mesenchymal transition in renal tubular cells in the
pathogenesis of progressive tubulo-interstitial fibrosis. Acta
Physiol Hung. 94:117–131. 2007. View Article : Google Scholar : PubMed/NCBI
|
